Note: Ingredients listed on restricted chemical lists
EC/CAS
270-115-0/68411-30-3
Name of the chemical
Benzenesulfonic acid,C10-13-alkyl derivs., sodium salts
Concentration
1 - 3
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<1
EC/CAS
215-279-6
Name of the chemical
Calcium carbonate
Concentration
30 - 60
General Information
Version
1.1
Revision date
2024-04-08
Product name
LUFRA CREAM
1.2.1 Relevant identified uses
Industrial uses,Professional uses Industrial/Professional use spec Industrial
1.2.2. Uses advised against
The product should not be used for purposes other than those shown above without first referring to the supplier and obtaining written handling instructions
Emergency telephone
+353 1 809 2566, +353 1 809 2166, 0344 892 0111
Icons in SDS
Company Information
company name
Christeyns España, SLU
e-mail address of the competent person responsible for the Safety Data Sheet
info.ES@christeyns.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07
Signal word
Warning
Hazard statements
H319 - Causes serious eye irritation.
Precautionary statements
P280 - Wear protective gloves, protective clothing, eye protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention.
Supplemental label elements
EUH208 - Contains METHYLCHLOROISOTHIAZOLINONE (AND) METHYLISOTHIAZOLINONE. May produce an allergic reaction.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Serious eye damage/eye irritation, Category 2 H319 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available
